Some people drink a double espresso at 4pm and sleep fine. Others get jittery and wired off a single cup of tea. This isn't willpower or tolerance built up over years — for a meaningful share of it, it's genetics. A specific gene, CYP1A2, controls how fast your liver breaks caffeine down, and the difference between "fast" and "slow" metabolizers is large enough to change how caffeine should factor into your day.
The gene that does the work
Roughly 95% of caffeine clearance happens through a single liver enzyme, cytochrome P450 1A2, encoded by the CYP1A2 gene.1 A common variant, often referred to by the marker rs762551 (the *1A/*1F polymorphism), affects how much of this enzyme your liver produces. People with the "fast" variant clear caffeine efficiently; people with the "slow" variant clear it much more gradually, meaning a given dose stays active in their system for longer and produces a stronger, longer-lasting effect from the same cup of coffee.
The same 95mg of caffeine can act like a light dose for one person and a strong one for another — purely based on how fast their liver clears it.
It isn't just about feeling jittery
The clearest evidence that this genetic difference matters clinically comes from cardiovascular research, not just subjective jitteriness. A large 2006 study published in JAMA followed over 4,000 adults and found that among slow CYP1A2 metabolizers, higher coffee intake was associated with an increased risk of nonfatal heart attack — an association that did not hold for fast metabolizers drinking the same amount of coffee.2 In other words, the same daily coffee habit carried measurably different cardiovascular risk profiles depending on this one genetic variant. That's a stronger claim than "some people just don't like caffeine" — it's evidence that genotype changes the actual physiological exposure, not just the perception of it. Worth noting, though: a much larger 2019 analysis of UK Biobank data — following over 347,000 people — did not find the same CYP1A2-by-coffee interaction for cardiovascular risk, so this specific finding is best read as suggestive rather than settled.4
Why "just build a tolerance" doesn't fully apply here
Regular exposure does blunt some of caffeine's subjective effects over days to weeks, but it doesn't change the underlying enzyme activity your genes set. A newer line of research using more detailed pharmacokinetic modelling has also found that the genetics of caffeine metabolism are more layered than a single fast/slow switch — some studies looking specifically at Caucasian populations found the classical *1F polymorphism didn't fully predict enzyme activity on its own, suggesting other genetic and environmental factors (smoking status being a major one — smoking substantially speeds up CYP1A2 activity) also shape how any individual processes caffeine.3 The practical point holds either way: caffeine sensitivity is real, physiological, and not something everyone can train their way out of.
What to actually do with this
If caffeine reliably disrupts your sleep, makes you anxious at doses that don't seem to bother other people, or you have a family history suggesting slower metabolism, the most useful response isn't more caffeine tolerance training — it's simply taking less, earlier in the day, and not assuming your reaction is unusual or a personal failing. If you have any cardiovascular risk factors, the JAMA finding above is a reasonable prompt to discuss your coffee and caffeinated-supplement intake with a doctor rather than guessing.
References
- Grzegorzewski J, Bartsch F, Köller A, König M. "Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing." Frontiers in Pharmacology, 2021. frontiersin.org
- Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. "Coffee, CYP1A2 genotype, and risk of myocardial infarction." JAMA, 2006. pubmed.ncbi.nlm.nih.gov
- Sachse C, et al. "Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians." Pharmacogenetics, 1999. pubmed.ncbi.nlm.nih.gov
- Zhou A, Hyppönen E. "Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases." American Journal of Clinical Nutrition, 2019;109(3):509-516. pubmed.ncbi.nlm.nih.gov
This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Speak with a healthcare provider before making changes to your caffeine intake, especially if you have a cardiovascular condition or take medication.
Related reading: Does Cognitive Support Contain Caffeine?
If you're sensitive to caffeine, know your dose: Cognitive Support's full ingredient list is on the label at procohq.com.